Questions
Tournaments
Services
News
Questions
Tournaments
Questions
Questions
More
Log in
Sign Up
a
/
文
Log in
Sign Up
38
comments
11
forecasters
When will the RSV monoclonal antibody nirsevimab (Beyfortus) no longer be in shortage in the US?
community
11 Oct 2024
result
01 Apr 2024 08:00
Share
Forecast Timeline
1d
1w
2m
all
Comments
Timeline
Question Info
Resolution Criteria
Background Info
Follow
embed
Authors:
RyanBeck
Opened:
Dec 21, 2023
Closes:
Jun 30, 2025
Resolved:
Apr 1, 2024
Spot Scoring Time:
Dec 24, 2023
Respiratory Outlook 2023/24
Economy & Business
Health & Pandemics
2021-2025 Leaderboard
Similar Questions
What will RSV immunization coverage for the 2025-26 season be among the following groups in the US?
Infants < 8 months
43.9
Eligible pregnant women
38.1
Adults 75+
55.6
13
forecasters
When will the maximum weekly rate of new hospital admissions per 100,000 people occur for the following respiratory illnesses in the 2025-2026 season?
RSV
03 Jan 2026
Flu
16 Jan 2026
COVID-19
04 Jan 2026
1 other
14
forecasters
When will an intranasal SARS-CoV-2 vaccine be approved by the US?
20 Jul 2026
(11 Aug 2025 - Jul 2031)
20 Jul 2026
(11 Aug 2025 - Jul 2031)
5
forecasters
Show More Questions